Metabolic Dysfunction Associated Steatohepatitis Clinical Trials
3 recruiting trials for Metabolic Dysfunction Associated Steatohepatitis. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have...
This study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called...
Sponsor: Boehringer IngelheimEnrolling: 159020 locations
RECRUITINGPhase 2NCT07288138
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO)...
The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on...
Sponsor: EccogeneEnrolling: 16020 locations
RECRUITINGNCT06138821
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the...
Sponsor: Pichamol Jirapinyo, MD, MPHEnrolling: 1322 locations